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Abstract
Background: Necrotizing enterocolitis (NEC) is a serious gastrointestinal disorder that is often seen in premature
infants. Probiotics decrease the risk of NEC; however, the mechanism by which probiotics work is not clear. The
goal of this study was to evaluate the preventive effect of Bifidobacterium adolescentis in an NEC rat model.
Methods: Sprague-Dawley neonatal rats were obtained by caesarean section after 20-21 d gestation and randomly
divided into the following 3 groups: dam fed (DF), formula fed (FF), and formula + B. adolescentis (FB). Those in the
FF and FB groups developed NEC after exposure to asphyxia and cold stress. All rats were sacrificed 72 h after birth
and intestinal injury and mRNA expression of TLR4, TOLLIP and SIGIRR were assessed.
Results: B. adolescentis significantly increased the 72-h survival rate from 56.3% in the FF group to 86.7% in the FB
group. B. adolescentis significantly reduced the histological score from a median of 3.0 in the FF group to a median
of 1.0 in the FB group,and significantly decreased the rate of NEC-like intestinal injury from 77.8% in the FF group
to 23.1% in the FB group. The mRNA expression of TLR4 increased 3.6 fold in the FF group but decreased by 2 fold
from B. adolescentis treatment. mRNA expression of TOLLIP and SIGIRR decreased 4.3 and 3.7 fold, respectively, in
the FF group. B. adolescentis significantly increased mRNA expression of TOLLIP and SIGIRR by 3.7 fold and 2.6 fold,
respectively.
Conclusions: This study demonstrated B. adolescentis prevents NEC in preterm neonatal rats and that the
mechanism for this action might be associated with the alteration of TLR4, TOLLIP, and SIGIRR expression.
Keywords: Necrotizing enterocolitis, Toll-like receptor 4, Toll interacting protein, single Ig IL-1-Related receptor
Background
Necrotizing enterocolitis (NEC) is a serious gastrointes-
tinal disorder that frequently affects premature newborns
and results in high morbidity and mortality, especially in
very low-birth weight (VLBW) infants [1, 2]. NEC affects
approximately 7.0% of all VLBW infants [1] and the death
rate associated with the disease is >20%, [1, 3] and nearly
one-half of NEC infants need surgery [4]. Premature new-
borns often must receive long-term parenteral nutrition.
These infants often develop NEC and are subsequently at
increased risk for short bowel syndrome and cholestatic
liver disease [4]. In addition, the premature infants with
NEC who need surgery are at increased risk for neurode-
velopmental disorders, such as microcephaly and cerebral
palsy [5]; therefore, it is important to identify a preventive
strategy that will reduce the risk of developing NEC.
Although much research has found that NEC might be
a multifactor disease with genetic susceptibility, prematur-
ity, formula feeding and abnormal microbial colonization
as risk factors, the exact pathophysiology of the disease re-
mains unknown [1, 6]. NEC pathogenesis is characterized
by intestinal inflammation [7] and it was recently sug-
gested that the disease is actually caused by excessive
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intestinal inflammation, which is associated with an
immature innate immune response, such as that in pre-
mature infants [8]. Toll-like receptors (TLRs) are a large
family of molecules that play a key role in the innate im-
mune response [9]. The ligand of one such TLR, TLR4, is
a lipopolysaccharide (LPS), a component of the cell wall of
Gram-negative bacteria [9]. TLR4 plays a role in the intes-
tinal immune response; it maintains low levels in mature
intestinal epithelium [10] but is overexpressed in human
fetal enterocytes [11], which predisposes immature intes-
tinal epithelium to excessive intestinal inflammation when
exposed to LPS. The results of a recent study that used an
experimental rat model in which NEC was induced by a
combination of formula feeding and hypoxia demon-
strated that TLR4 mutant mice were more protected from
NEC development compared to wild-type mice [10]. It
was also reported that intestinal epithelial TLR4 inhibits
enterocyte proliferation and migration [12], and that
endothelial TLR4 impairs intestinal microcirculatory per-
fusion [13], suggesting that TLR4 plays an important role
in NEC pathogenesis.
TOLLIP and SIGIRR proteins are negative regulators
of TLR4 signaling and play an inhibitory role in the
TLR-mediated pathway [14, 15]. It was recently reported
that they also play an important role in intestinal inflam-
mation [16, 17]. These negative regulators inhibit the
signal from TLR4 to downstream pathways by suppress-
ing the activity of interleukin (IL)-1 receptor-associated
kinase (IRAK), which is a crucial molecule in the TLR4
signaling pathway [14]. After exposure to dextran sulfate
sodium (DSS) for 5.0 d, TOLLIP-deficient mice showed
increased severity of intestinal symptoms and greater ex-
pression of proinflammatory cytokines compared with
wild-type mice [16]. In addition, the level of SIGIRR de-
creased in ulcerative colitis patients and in the experi-
mental colitis mouse model [17]. There is less TOLLIP
and SIGIRR mRNA in immature enterocytes and even
less in NEC enterocytes compared with that in mature
enterocytes [4]. These results suggest that both TLR4
and its negative regulators may play a critical role in the
development of NEC.
Bifidobacterium is one type of probiotic, which are live,
beneficial microorganisms that predominate in the intes-
tinal flora of breast-fed infants [18]. Recent clinical studies
have shown that oral administration of B. infantis and B.
bifidum could prevent NEC development in premature in-
fants [19, 20]. It is not entirely clear how Bifidobacterium
species protect the neonatal intestine against NEC, but
recent reports show that B. infantis exerts an anti-
inflammatory effect by decreasing TLR4 mRNA and in-
creasing TOLLIP and SIGIRR mRNA levels in immature
human intestinal xenografts and NEC intestinal epithelial
cells [4]. It is unknown whether B. adolescentis has the
same effect in the NEC rat model; therefore, the aim of
this study was to determine whether B. adolescentis could
protect against NEC and whether TLR4, TOLLIP and
SIGIRR expression could be influenced by B. adolescentis.
Methods
Animal model
All animal experiments were reviewed and approved by
the Animal Care and Welfare Committee of Guangzhou
Medical University (Guangzhou, China). All animal ex-
periments were performed in accordance with the U.S.
National Institutes of Health’s “Guide for the Care and
Use of Laboratory Animals” (NIH Publications No. 80-
23 revised 1996). Every effort was made to minimize the
number of animals used and reduce suffering. Adult
Sprague-Dawley (SD) rats were purchased from
Guangdong Medical Laboratory Animal Center (Foshan,
China). They were housed at the Guangzhou Medical
University Laboratory Animal Center and kept in a
room at 22 °C, with a 12-h light-dark cycle [21]. Prema-
ture pups were delivered from time-dated pregnant SD
rats by Cesarean section 20-21 d of gestation and were
reared in incubators at 37 °C [10].
Forty five premature pups were randomly divided into
the following three groups: dam fed (DF, n = 14), formula
fed (FF, n = 16), and formula + B. adolescentis (FB, n = 15).
Pups in the DF group were fed by surrogate mothers, and
the newborn rats in the FF and FB groups were fed 2.0 h
after birth with Esbilac puppy formula (PetAg, Inc.,
Hampshire, IL, USA). Feeding started with 0.15 mL every
4.0 h and advanced, as tolerated, to a maximum of
0.20 mL per feeding after 24 h of life through a home-
made orogastric feeding catheter. Premature newborn rats
from the FB group were treated with 1.0 × 108 CFU live B.
adolescentis per day, (Livzon, Zhuhai, China) diluted in
formula.
NEC protocol was followed in the FF and FB groups
after the first feeding. Experimental NEC was induced by
90 s of 100% nitrogen exposure and subsequent 10 min
cold exposure (4.0 °C) twice daily for 72 h. Rats in the
DF group were fed by surrogate mothers and not ex-
posed to asphyxia or cold stress [18].
Sample collection and tissue processing
After termination, all premature rats were euthanized by
neck dislocation and laparotomies were performed. A
2.0-cm piece of distal ileum was removed and stained
with hematoxylin and eosin (H&E) and used for RNA
extraction. One-half of each intestinal specimen was
fixed in 4.0% paraformaldehyde, paraffin embedded, cut
into 4.0-μm sections, and stained with H&E to observe
the histological changes under an optical microscope.
The remaining one-half of each intestinal tissue was
washed with cold normal saline (4.0 °C) and stored in
liquid nitrogen for subsequent RNA analysis.
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Histological changes in the ileum were evaluated by a
blinded assessor using the following NEC scoring criteria
[18]: 0 (normal), no damage; 1 (mild), slight submucosal
and/or lamina propria separation; 2 (moderate), moder-
ate separation of submucosa and/or lamina propria, and/
or edema in submucosal and muscular layers; 3 (severe),
severe separation of submucosa and/or lamina propria,
and/or severe edema in submucosa and muscular layers,
regional villi sloughing; 4 (necrosis), loss of villi and ne-
crosis. Scores ≥2 represented NEC-like intestinal
damage.
RNA extraction and quantitative polymerase chain
reaction
The mRNA expressions of TLR4, TOLLIP, and SIGIRR
were evaluated using GAPDH as the endogenous gene
control by real-time quantitative polymerase chain reac-
tion (RT-qPCR). Total RNA was extracted from frozen
ileal tissue using the HiPure Total RNA Mini Kit
(Magen, Guangzhou, China) and following the manufac-
turer’s instructions. RNA integrity was verified by agar-
ose gel electrophoresis. The purity and concentration of
RNA were quantified using the Nanodrop ND-1000 UV
Spectrophotometer (Thermo Fisher Scientific, Waltham,
MA, USA).
Reference Sequence Database access codes were as fol-
lows: NM_019178 (TLR4), NM_001109668 (TOLLIP),
NM_001024887 (SIGIRR), and NM_017008.4 (GAPDH).
TLR4 upstream primers were 5′-TATCCAGAGCCGTT
GGTGTATT-3′ and the downstream primers were 5′-
AATGAAGATGATGCCAGAGCG-3′. The length of the
PCR product was 85 base pairs (bp). TOLLIP upstream
primers were 5′-CCAAGTGGAGGACGAGTGGTAT
-3′ and the downstream primers were 5′-GCTTCAAG-
CACAGAACGGATT-3′. The length of the PCR product
was 330 bp. SIGIRR upstream primers were 5′-
TGGTGAACCTGAGTCGCTGTC -3′ and the down-
stream primers were 5′-CCCTCCACGGGTCTCTAT
TG-3′. The length of the PCR product was 310 bp.
GAPDH upstream primers were 5′-TTCCTACCCC-
CAATGTATCCG-3′ and the downstream primers were
5′-CATGAGGTCCACCACCCTGTT-3′. The length of
the PCR product was 281 bp. PCR primers were de-
signed using the Primer-BLAST tool (NCBI, Bethesda,
MD, USA) and synthesized by Goodbio Technology
Company (Wuhan, China). cDNA was synthesized using
the PrimeScript™ RT Reagent Kit (TaTaRa, Dalian,
China) and following the manufacturer's instructions.
mRNA levels were detected in triplicate using SYBR
Premix Ex Taq™ Kit (Takara, Dalian, China) on a
Mx3000P (Stratagene, California, La Jolla, CA, USA)
with a 20-μL RT-qPCR reaction mixture. The amplifica-
tion reaction was started at 95 °C for 60 s for initial de-
naturation, followed by 40 consecutive PCR cycles at
95 °C for 5.0 s, and 60 °C for 30 s. The fold changes in
specific gene expression were calculated using the ##CT
method [22].
Statistical analyses
The statistical analyses were conducted using SPSS13.0
software (Armonk, NY, USA). mRNA expression of TLR4,
TOLLIP and SIGIRR are presented as the mean ± SE.
The difference in expression among DF, FF, and FB groups
was analyzed using one-way analysis of variance followed
by the Student–Newman–Keul multiple comparisons test.
The Mann–Whitney test was used to compare different
pathological ileum scores between the FF and FB groups.
Survival time was analyzed using Kaplan–Meier analysis
(with the log-rank test). The incidence of NEC-like
intestinal injury was evaluated using the Fisher's exact test.
P < 0.05 was considered statistically significant. All ana-
lyses were two-tailed tests.
Results
General status
There were no statistically significant differences in birth
weight among the three groups: Throughout the entire
experiment, the premature rats in the DF group in-
creased their weight. The rats in the FB group main-
tained their body weight but those in the FF group
gradually lost body weight, one symptom of the disease.
The mean body weight of rats in the DF, FF group and
FB groups was 7.90 ± 0.50 g, 5.58 ± 0.73 g and 6.40 ±
0.67 g, respectively, with a statistically significant differ-
ence at the end of the 72 h (P < 0.001). The other NEC-
like symptoms appeared between 48 and 72 h; these
were abdominal distension and diarrhea, which were simi-
lar to those described in a previous study [23]. The mean
survival time was 64.8 h (64.8 ± 2.3) in the FF group and
71.3 h (71.3 ± 0.5) in the FB group. The 72-h survival rates
in the FF, FB and DF groups were 56.3 (9/16), 86.7 (13/15)
and 100% (14/14), respectively. Rats in the FB group had a
significantly better survival rate than those in the FF group
(P = 0.005, Fig. 1).
Effects of B. adolescentis on the incidence and severity of
NEC-like injury in neonatal rats
The ileal histological score was lower in the FB group (me-
dian, 1.0) than in the FF group (median, 3.0) (P= 0.013).
Administration of B. adolescentis significantly decreased the
rate of NEC-like intestinal injury from 77.8% (7/9) in the FF
group to 23.1% (3/13) in the FB group (P= 0.027). In the DF
group, the incidence of NEC-like intestinal injury was 0%
(0/14) and the median histological score was 0 (Fig. 2).
Representative images from each group are shown in Fig. 3a,
b and c.
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Evaluation of mRNA expression of TLR4, TOLLIP, and
SIGIRR in the ileum tissues
The ileum mRNA expression of TLR4 increased by 3.6
fold in the FF group compared with that in the DF group
(P < 0.05), while the expression of TLR4 mRNA de-
creased by 2.0 fold as a result of B. adolescentis treat-
ment (P < 0.05) (Fig. 4a). In contrast, the mRNA
expression of TOLLIP and SIGIRR decreased 4.3 and 3.7
fold in the FF group, respectively compared with those
in the DF group (P < 0.05) (Fig. 4b and c). Administra-
tion of B. adolescentis significantly increased mRNA ex-
pression of TOLLIP and SIGIRR by 3.7 and 2.6 fold,
respectively (P < 0.05) (Fig. 4b and c). There was no
statistical difference in mRNA expression of TLR4,
TOLLIP, or SIGIRR between the FB and DF groups (P >
0.05).
Discussion
The model used is a well-established NEC model [24]
that is based on the induction of intestinal injury using
formula feeding and hypoxia-hypothermia treatment as
two critical instigating factors on premature rats [24].
Previous studies [23, 25] suggested that all dam-fed pups
or pups without exposure to hypoxia-hypothermia
showed normal intestinal histology or less intestinal in-
jury. We recognize that NEC development in human in-
fants is more complex, thus the pathophysiology of a rat
model might be different from that seen in humans;
however, we used this model to explore the protective
effect of B. adolescentis on pathophysiologic mechanisms
associated with NEC.
In this study, prophylactic B. adolescentis significantly
alleviated ileum damage in the NEC rat model, and also
inhibited the increase in TLR4 expression and the de-
crease in TOLLIP and SIGIRR expression in the intes-
tine. These results indicated that B. adolescentis protects
premature rats from intestinal injury from hypoxia and
cold stress, the mechanism of which might be by redu-
cing the expression of TLR4 and increasing the expres-
sion of TOLLIP and SIGIRR.
Although the pathogenesis of NEC is not entirely
known [1],the theory that inappropriate microbial
colonization in the intestine induces the immature intes-
tine to mount an excessive inflammatory response that
results in tissue injury and necrosis is a consideration
[1]. IL-8 increases in response to inflammatory stimuli
in immature enterocytes compared with mature entero-
cytes [26]. It was reported that the same effect is seen in
animal models, intestinal explants, and xenografts [27].
Clinical observation has shown that patients with NEC,
especially infants who need surgery, have much higher
levels of proinflammatory cytokines [28].
TLR4 is activated by LPS, a Gram-negative bacteria in
the cell wall and the main ligand for TLR4, then signal
through MyD88 to promote the production and release
of proinflammatory cytokines though NF-κB [7]. Myd88
is a TLR4 adaptor molecule that is recruited to TLR4
and subsequently recruits IRAK [7]. TOLLIP and
SIGIRR impair signaling from TLR4 by suppressing
IRAK, which results in reducing the synthesis of proin-
flammatory cytokines [14]. TOLLIP binds to IRAK and
inhibits IRAK phosphorylation [16] to downregulate the
TLR4 signal. SIGIRR impairs TLR4 signaling that leads
to NF-κB activation by competing with MyD88 and
IRAK recruitment at the Toll-IL-1-receptor (TIR) do-
main [29], which participates in the interaction of
SIGIRR with TLR4 [30]. Nanthakumar [8] suggested that
Fig. 1 Kaplan–Meier survival analysis. The mean survival time was 64.8 h
(64.8 ± 2.3) in the formula fed (FF) group and 71.3 h (71.3 ± 0.5) in the
formula + Bifidobacterium adolescentis (FB) group. Rats in the FB group had
a significantly better 72-h survival rate than in the FF group (P < 0.05)
Fig. 2 Necrotizing enterocolitis (NEC) histological score of ileum in each
group. Histological scoring of the terminal ileum of premature newborn
rats in dam-fed (DF), formula-fed (FF), and formula + Bifidobacterium
adolescentis (FB) groups (DF, n= 14; FF, n= 9; FB, n= 13). NEC-like intestinal
damage was defined as scores ≥ 2. *indicates P < 0.05
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the inappropriate inflammatory response in the imma-
ture intestine is a result of the imbalance between TLR4
and its negative regulators. TLR4 and chemokine expres-
sion is greater in both fetal and NEC enterocytes than
that in mature human enterocytes [8]. SIGIRR and TOL-
LIP expression, which inhibits the inflammatory reac-
tion, is lesser in both immature and NEC enterocytes
than that in mature enterocyte [8]. In this study, we
demonstrated that the level of TLR4 increases while the
level of negative effector molecules decreases. Accord-
ingly, it is reasonable to speculate that NEC is related to
TLR4 and its negative regulators.
Many treatments have been proposed to prevent
NEC but few have proved promising [1]. The most
recently reported multicenter trial suggested that
prophylactic probiotic treatment decreases the inci-
dence of NEC [19, 31, 32]. Bifidobacterium is one
type of Gram-positive probiotic that quantitatively
colonizes in the intestine more than Gram-negative
pathogenic bacteria [19, 31, 32]. Bergmann et al. [33]
reported that the administration of B. infantis inhibits an
increase in intestinal permeability and reduces NEC inci-
dence in the NEC neonatal mouse model. B. longum
subsp. infantis decreases the level of proinflammatory cy-
tokines, which are important in NEC pathogenesis [34]. It
was also reported that probiotics attenuates TLR4 expres-
sion in the NEC rat model at the protein level [34]. Re-
cently, Ganguli et al. [4] reported that TOLLIP and
SIGIRR mRNA levels increase and TLR4 mRNA level
decreasese when immature human intestinal xenografts
incubate with conditioned media of B. infantis, and that
TOLLIP and SIGIRR mRNA expressions also increase in
NEC intestinal epithelial cells. In this study, we demon-
strated that B. adolescentis confers significant protection
against intestinal injury in the NEC premature rat model
and alter the expression of TLR4, TOLLIP and SIGIRR, all
factors in the NF-κB signaling pathway; therefore, we
speculate that B. adolescentis modulates the NF-κB signal-
ing pathway by upregulateing TOLLIP and SIGIRR, and
decreasing TLR4 to protect against intestinal injury.
Fig. 3 Histological changes of ileum in premature newborn rats. The representative images from each group are presented. (a) The structure of
intestinal mucosa is intact in the dam-fed (DF) group; (b) the structure of ileum villus was broken and even lost in the formula-fed (FF) group; (c)
the ileum of premature rats in formula + Bifidobacterium adolescentis (FB)group had less necrotic ilea and lost villi. Scale bar represents 100 μm.
Original magnification: 200 ×
Fig. 4 Fold changes in the relative mRNA expression of TLR4, TOLLIP, and SIGIRR of the ileum of premature neonatal rats in dam-fed (DF), formula-fed
(FF), and formula + Bifidobacterium adolescentis (FB) groups. The mRNA expression of TLR4 (a), TOLLIP (b), and (c) SIGIRR(B) in DF, FF, and FB groups
(DF, n = 14; FF, n = 9; FB, n = 13) is shown. The mRNA expression for the DF group is set a value of 1.0, and mRNA levels for the FF and FB groups are
determined relative to this number. Values are presented as the mean ± SE. *indicates P < 0.05
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Probiotics exert their anti-inflammatory effects to re-
duce the incidence of NEC, but the mechanism is not
known. These effects might be mediated by products se-
creted by probiotic bacteria. Probiotic conditioned media
contain secreted products, free of intact bacteria, and it
was recently reported that this media reduces NEC-like
intestinal damage in an animal model [35]. Probiotic
conditioned media inhibites the NF-κB signaling path-
way and its proinflammatory cytokine production [36],
which contributes to attenuating the intestinal inflam-
matory response [36]. It was also reported that Bifido-
bacterium-conditioned media reduces the level of TLR2
and TLR4 in xenograft epithelium and increases the
level of SIGIRR and TOLLIP [4]; therefore, it is reason-
able to speculate that Bifidobacterium species might al-
leviate intestinal injury through their secreted products,
although what the probiotic conditioned media contains
is not clear. Ganguli [4] suggested that a protein or nu-
cleic acid from 5.0 to 10 kDa, might be in the media;
however, Shiou [35] suggested that it is not a protein.
This controversy will require further experiments, which
is beyond the scope of the current study.
Another possible bioactive effector that protects pre-
mature rats from NEC might be some component of
killed bacteria [37]. It was recently reported that heat-
killed probiotics are as effective as live probiotics in
maintaining the intestinal barrier [38] and that they can
alleviate intestinal inflammation [39]. Both TOLLIP and
SIGIRR are closely related to the intestinal barrier. Intes-
tinal permeability in TOLLIP-deficient [16] and SIGIRR-
deficient mice [40] treated with DSS increases compared
with that in wild-type controls. It was also reported that
the heat-killed probiotics alleviate intestinal inflamma-
tion through the downstream TLR4 pathway [41]. Dead
Lactobacillus, which were isolated from newborn infant
feces and breast milk, as well as live bacteria, activate
TLR4-associated negative regulators, including TOLLIP,
SOCS1, SOCS3 and IκBα [41]. It appears that the pro-
tective effect of B. adolescentis on NEC might be the re-
sult of upregulating SIGIRR and TOLLIP using some
component of dead B. adolescentis.
Conclusions
We believe that prophylactic B. adolescentis protects
against intestinal injury in a well-established premature
newborn rat model, and inhibits the increase in intes-
tinal TLR4 and the decrease in TOLLIP and SIGIRR ex-
pression. These results help to gather insight into the
mechanisms behind the protective effects of probiotics
in the intestine; however, in this study the increases in
the expression of both SIGIRR and TOLLIP were dem-
onstrated only in the NEC rat model, further studies are
required to better determine the mechanisms underlying
the beneficial effects of probiotics.
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